Evogliptin Tartrate-impurities | Pharmaffiliates

evogliptin tartrate and its Impurities

Evogliptin tartrate is a dipeptidyl peptidase IV inhibitor, in tablet form. Evogliptin tartrate tablets is expected to be approved for the treatment of type 2 diabetes mellitus. Reference standards of Evogliptin Tartrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for evogliptin tartrate Impurities
PA 05 66000

Evogliptin Tartrate - API

Evogliptin Tartrate


  • Catalogue No.:PA 05 66000

  • CAS :

    1222102-51-3

  • Molecular Formula : C23H32F3N3O9

  • Molecular Weight : 551.51

PA 05 66510

Evogliptin Tartrate Impurity S1

Evogliptin Tartrate Impurity S1


  • Catalogue No.:PA 05 66510

  • CAS :

    NA

  • Molecular Formula : C23H32F3N3O9

  • Molecular Weight : 551.51

PA 05 66520

Evogliptin Tartrate Impurity S2

Evogliptin Tartrate Impurity S2


  • Catalogue No.:PA 05 66520

  • CAS :

    NA

  • Molecular Formula : C23H32F3N3O9

  • Molecular Weight : 551.51

PA 05 66530

Evogliptin Tartrate Impurity S3

Evogliptin Tartrate Impurity S3


  • Catalogue No.:PA 05 66530

  • CAS :

    NA

  • Molecular Formula : C23H32F3N3O9

  • Molecular Weight : 551.51